{
    "title": "Zogenix stock soars on epilepsy drug trial success",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-4933234/Zogenix-epilepsy-drug-meets-main-goal-late-stage-trial.html",
    "date": "2017-09-29",
    "keywords": [
        "treatment",
        "drug",
        "latestage",
        "trial",
        "dravet",
        "epilepsy",
        "company",
        "gw",
        "placebo",
        "number",
        "analyst",
        "zx008",
        "half",
        "form",
        "goal",
        "study",
        "friday",
        "value",
        "peer",
        "dysfunction",
        "brain",
        "disorder",
        "longlasting",
        "zogenix",
        "premarket",
        "trading",
        "percent",
        "drugmaker",
        "application",
        "month",
        "market",
        "combination",
        "therapy",
        "patient",
        "phil",
        "nadeau",
        "report",
        "year",
        "track",
        "europe",
        "syndrome",
        "type",
        "yearend",
        "chief",
        "executive",
        "stephen",
        "farr",
        "call",
        "lead",
        "pharma",
        "reporting",
        "bengaluru",
        "editing",
        "graham",
        "sai",
        "sachin",
        "ravikumar"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}